Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Income towards Parent Company (2010 - 2018)

Achieve Life Sciences' (ACHV) quarterly Income towards Parent Company came in at -$3.6 million in Q4 2018, up 2.75% YoY from -$3.5 million in Q4 2017, and down 12.25% on a QoQ basis from -$3.2 million in Q3 2018.

Analysis

Achieve Life Sciences (ACHV) Income towards Parent Company (2010 - 2018) Analysis & Trends

Achieve Life Sciences (ACHV) has 7 years of Income towards Parent Company data on file, last reported at -$3.6 million in Q4 2018.

  • Quarterly Income towards Parent Company rose 2.75% year-over-year to -$3.6 million in Q4 2018, while the trailing twelve-month figure through Sep 2019 was -$3.6 million (up 71.56% YoY) and the FY2019 annual result came in at -$16.4 million, down 29.23% from the prior year.
  • Income towards Parent Company fell to -$3.6 million in Q4 2018, from -$3.2 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$166000.0 in Q2 2017 to a low of -$9.4 million in Q3 2017.
  • A 4-year average of -$2.6 million and a median of -$2.8 million in 2018 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2017 — Income towards Parent Company sank 2220.99% — and 2018, when it soared 65.53%.
  • Tracing ACHV's Income towards Parent Company over 4 years: stood at -$1.2 million in 2015, then surged by 50.36% to -$613000.0 in 2016, then plunged by 510.11% to -$3.7 million in 2017, then rose by 2.75% to -$3.6 million in 2018.
  • The last three Income towards Parent Company figures came in at -$3.6 million (Q4 2018), -$3.2 million (Q3 2018), and -$2.8 million (Q2 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.64 Mn
Sep 30, 2018 -3.24 Mn
Jun 30, 2018 -2.79 Mn
Mar 31, 2018 -3.02 Mn
Dec 31, 2017 -3.74 Mn
Sep 30, 2017 -9.40 Mn
Jun 30, 2017 -166,000.00
Mar 31, 2017 -329,000.00
Dec 31, 2016 -613,000.00
Sep 30, 2016 -405,000.00
Dec 31, 2015 -1.24 Mn
Dec 31, 2012 -38.09 Mn
Sep 30, 2012 5.92 Mn
Jun 30, 2012 4.22 Mn
Mar 31, 2012 -6.86 Mn
Dec 31, 2011 -19.78 Mn
Sep 30, 2011 -4.47 Mn
Jun 30, 2011 6.53 Mn
Mar 31, 2011 -3.05 Mn
Dec 31, 2010 -2.80 Mn